Measuring Fluorescence in Bacterial Cultures: A Lab Protocol Overview

Three major issues commonly encountered in multiplex fluorescent assays require specific troubleshooting approaches: (1) Autofluorescence - most problematic in FFPE tissues due to longer fixation times; solutions include using V2 assay formulated for FFPE tissues, placing highest expressing markers in green channel, and employing multispectral imaging software like Nuance for background subtraction; (2) Protease digestion optimization - critical for optimal staining; follow user manual guidelines, with fresh frozen tissues requiring ~30 minutes at room temperature; over-digestion causes high autofluorescence masking signals; (3) Microscopy issues - wrong filter settings, incorrect exposure, or inappropriate image enhancement; recommendations include using correct filters, avoiding auto-exposure initially, verifying signals with naked eye, and using proper image analysis software.

Common troubleshooting for autofluorescence in tissues like kidney, intestine, colon, and brain: (1) Use v2 assay with TSA concentration starting at 1:1500, (2) Assign the highest expressing target to the green channel for better signal-to-noise ratio, (3) Use multispectral imaging software to subtract background autofluorescence.

Self-quenching occurs when high concentrations of fluorescent molecules cause mutual interactions that reduce overall fluorescence intensity. At very high concentrations, excited molecules collide with ground-state molecules before they can emit light, transferring energy non-radiatively. The inner filter effect occurs when excessive sample concentration absorbs too much of the excitation light, reducing the amount reaching the sample and thus decreasing fluorescence emission. Both effects limit the linear range of fluorimetric measurements and require careful optimization of sample concentration for accurate quantitative analysis.

The inner filter effect occurs when high concentrations cause some light to be absorbed before reaching fluorophores (primary effect) or when emitted light is reabsorbed by other molecules (secondary effect). Both reduce the observed fluorescence signal below ideal expectations. This concentration-dependent artifact limits the linear range of fluorescence measurements.

Key errors in fluorescence measurements include: (1) High absorbance (>0.1) causes inner filter effects where excitation light is absorbed before reaching the sample center, reducing measured fluorescence; (2) Fluorescence reabsorption when emission spectrum overlaps with absorption spectrum; (3) Dimer formation at high concentrations (e.g., pyrene forms excimers with blue fluorescence instead of monomer's violet fluorescence); (4) Raman scattering from solvent can be subtracted by measuring blank solvent. These errors must be minimized for accurate fluorescence measurements.

Multi-day kinetic assays can be performed using the GloMax Discover plate reader with pre-installed protocols in the GloMax software. The instrument is pre-warmed to the desired temperature before use. This approach allows researchers to develop new luminescent live cell reagent assays, such as the realtime glow family of live cell assays.

Fluorescence kinetics are tracked every 30 minutes for eight hours on both Earth and in space. Images are normalized and quantified, with results compared between locations. Similar results are expected where the first two tubes continue fluorescing red throughout the assay, while the second tube with complementary RNA shows transition to green fluorescence as the reaction progresses.

Reporter assays measure promoter activity by fusing a coding sequence (such as luciferase) behind a promoter of interest. The DNA is introduced into cells where it can be transiently expressed. After a period of time, extracts are made and luciferin and ATP are added to measure luciferase activity. While this reflects the amount of messenger RNA accumulating, it doesn't account for all factors and is subject to interpretation.

A Gaussian process model can represent promoter activity over time as a flexible non-parametric function. The model accounts for cell population desynchronization over time by incorporating a Gaussian kernel that spreads the signal out over time. This spreading effect captures how initially synchronized cells become less synchronized as monitoring continues. The model then infers time delays for reaching different segments of the gene using Bayesian inference methods like Hamiltonian Monte Carlo, without assuming constant elongation velocity.

Stepseek is a massively parallel reporter assay developed in the lab to measure promoter activity. The promoter library (72,000 candidates from Twist oligopools covering every promoter in the Drosophila genome) is cloned into the core promoter position of the reporter plasmid. Promoters are co-transfected together with a single co-factor fused to the DNA binding domain of Galf. If a co-factor activates a specific promoter, reporter transcripts are produced with unique sequence tags allowing identification. Unique molecular identifiers (UMIs) enable precise quantification of individual molecule counts.

High-throughput screening (HTS) is a robotic-based methodology that enables researchers to rapidly conduct millions of chemical, genetic, or pharmacological tests using microtiter plates (typically 384, 1536, or 3456 wells) to identify active compounds, antibodies, or genes that modulate specific biomolecular pathways; the process involves preparing assay plates from stock compound libraries, measuring biological responses through automated analysis systems, and applying statistical methods including Z-scores, signal-to-noise ratios, and strictly standardized mean difference (SSMD) for quality control and hit selection, with recent advances in microfluidics enabling screening speeds up to 1,000 times faster than conventional techniques.

High Throughput Screening (HTS) is an unbiased, automated technology used in drug discovery to rapidly screen large compound collections (typically 200,000-800,000 compounds) against biological targets to identify 'hits'—compounds that show initial activity—which are then refined through iterative testing, counter-screening, and medicinal chemistry optimization to develop into drug candidates with desired pharmacological properties.

High Throughput Screening (HTS) is an early-stage drug discovery process that rapidly screens large compound libraries (e.g., 1.6-1.7 million compounds) against validated disease targets to identify chemical series for further optimization into potential drugs. HTS functions like a funnel, starting with millions of compounds and progressively narrowing down to tens to hundreds of compounds comprising 4 chemical series for later development stages. Robotics and automation enable rapid screening of large numbers of compounds efficiently.

NCATS uses 1536-well microtiter plates for high-throughput screening, providing 15 times more data than 96-well plates with the same reagent/cell volume. Technologies include reporter genes (fluorescent protein tagging, bioluminescent reporters) and high-content imaging cores. NCATS maintains extensive chemical libraries: over 350,000 synthetic molecules, commercially available libraries, biologically annotated chemicals from literature, and the NCATS pharmaceutical collection containing all FDA-approved drugs and phase three clinical trial compounds. This collection enables rapid repurposing since compounds have already passed clinical trials.

Flow cytometry is a powerful analytical technique that enables high-throughput single-cell measurements, providing both high dynamic range (3-6 orders of magnitude) and detailed information about cell distributions, which is essential for understanding biological systems and debugging experimental protocols; the technique works by suspending cells in fluid and passing them through one or more lasers, measuring forward scatter (cell size), side scatter (granularity), and fluorescence emissions, with modern instruments reporting three pulse parameters (area, width, and height) for each cell event, though researchers must carefully configure gating strategies and account for cell size limitations and potential contamination issues.

Cytometry measures physical/chemical characteristics of cells at single-cell level. Three major categories: (1) Flow cytometry - quantitative, millions of cells, no spatial resolution; (2) Microscopy - spatial resolution, limited parameters/cells; (3) Genomic cytometry - high-dimensional profiling of genome/transcriptome/proteome. Spectral cytometry differs from conventional flow by capturing entire emission spectra rather than single channels, enabling spectral fingerprinting. Benefits include: more data points per fluorophore (up to 64), more photons collected reducing errors, more fluorochromes with fewer lasers (40 colors with 5 lasers vs. 28 with 10), and autofluorescence extraction capability.

Flow cytometry enables analysis of individual cells from complex mixtures by passing them through a narrow channel where lasers excite fluorescently labeled antibodies. Each antibody recognizes specific cell surface proteins and is conjugated to a fluorophore emitting characteristic light when excited. Detectors capture these emissions to identify and quantify specific cell populations. Single-cell analysis reveals heterogeneous populations that population-level measurements cannot detect—for example, identifying rare but functionally important cell subsets that would be obscured by averaging. Modern spectral flow cytometers can analyze dozens of parameters simultaneously, providing comprehensive profiling of immune cell states including activation status, tissue origin, and glycan expression. This technology is essential for understanding immune landscape dynamics in health and disease.

Flow cytometry has evolved through two major developments: new fluorophores enabling 45-color panels and technological advances allowing 30+ parameter simultaneous measurement. Spectral cytometry revolutionized the field by capturing entire emission spectra rather than selected bands, enabling all fluorophores to be used simultaneously with small sample volumes. Mass cytometry further advanced multiplexing by using metal-isotope-labeled antibodies analyzed via time-of-flight mass spectrometry, achieving over 40 parameters per cell. Single-cell protein measurement relies primarily on ELISA-based approaches. Single molecule arrays (Simoa) achieve extreme sensitivity (down to ~30 molecules/cell) through digital bead-based detection in over 200,000 wells. Barcoded chip technology enables multiplexed secretome analysis by stimulating cells in bulk, then measuring cytokine secretion against 32+ antibodies simultaneously. Milo provides single-cell Western blot validation for connecting transcriptomic findings to protein expression.

Traditional lysate-based methods measure average protein levels across blended cell populations, producing only one data point per condition and preventing multivariate analysis. Single-cell technologies like flow cytometry and mass cytometry revolutionize biology by measuring individual cells, generating thousands of data points per experiment. This shift enables comprehensive characterization of cellular heterogeneity and complex signaling networks that were previously invisible to population-level approaches.